Literature DB >> 8889947

Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: neurochemical correlates of selective vulnerability.

B M Morrison1, J W Gordon, M E Ripps, J H Morrison.   

Abstract

Transgenic mice with a G86R mutation in the mouse superoxide dismutase (SOD-1) gene, which corresponds to a mutation that has been observed in familial amyotrophic lateral sclerosis (ALS), display progressive loss of motor function and provide a valuable model of ALS. The pathology in the spinal cords of these mice was evaluated to determine whether there are chemically identified populations of neurons that are either highly vulnerable or resistant to degeneration. Qualitatively, there were phosphorylated neurofilament protein (NFP)-immunoreactive inclusions and a pronounced loss of motoneurons in the ventral horn of the spinal cord without the presence of vacuoles that has been reported in other SOD-1 transgenic mice. Neuron counts from SOD-1 and control spinal cords revealed that the percentage loss of NFP-, choline acetyltransferase (ChAT)-, and calretinin (CR)-immunoreactive neurons was greater than the percentage loss of total neurons, suggesting that these neuronal groups are particularly vulnerable in SOD-1 transgenic mice. In contrast, calbindin-containing neurons did not degenerate significantly and represent a protected population of neurons. Quantitative double-labeling experiments suggested that the vulnerability of ChAT- and CR-immunoreactive neurons was due primarily to the presence of NFP within a subset of these neurons, which degenerated preferentially to ChAT- and CR-immunoreactive neurons that did not colocalize with NFP. Our findings suggest that NFP, which has been demonstrated previously to be involved mechanistically in motoneuron degeneration, may also be important in the mechanism of degeneration that is initiated by the SOD-1 mutation.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1996        PMID: 8889947     DOI: 10.1002/(SICI)1096-9861(19960930)373:4<619::AID-CNE9>3.0.CO;2-4

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  21 in total

1.  Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.

Authors:  M D Nguyen; R C Larivière; J P Julien
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 2.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

Review 3.  A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis.

Authors:  Kari A Trumbull; Joseph S Beckman
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

Review 4.  Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeutics.

Authors:  P C Wong; H Cai; D R Borchelt; D L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

5.  Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS.

Authors:  Christian S Lobsiger; Michael L Garcia; Christopher M Ward; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-07       Impact factor: 11.205

Review 6.  Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis.

Authors:  P J Shaw; C J Eggett
Journal:  J Neurol       Date:  2000-03       Impact factor: 4.849

7.  Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant.

Authors:  T L Williamson; L I Bruijn; Q Zhu; K L Anderson; S D Anderson; J P Julien; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

8.  Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase.

Authors:  S Couillard-Després; Q Zhu; P C Wong; D L Price; D W Cleveland; J P Julien
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models.

Authors:  Mohit Raja Jain; Wei-Wen Ge; Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2008-05-01       Impact factor: 3.494

Review 10.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.